NIH R01 Grant 2026: Deadlines, Fit, Success Rates
Updated 10 official sources
Quick Answer: The NIH R01 is the main research project grant mechanism, but "R01" is not one single competition.
Full answer and how we checked it
Your real decision is which notice, institute, study section, budget path, and clinical-trial status fit your project. NIH reported the R01-equivalent success rate fell to 13.0% in FY2025. October 5, 2026 has passed: the next standard new R01 date is February 5, 2027, and resubmissions use November 5, 2026, but the exact notice controls.
This guide is for PIs, research administrators, and grant writers deciding whether an NIH R01 grant is the right 2026 route or whether the project should start with R21, R03, K, U01, foundation, or pilot funding.
Source review by Grantsights, September 23, 2026: We rechecked NIH's R01 activity code, PA-25-301, standard due dates, simplified review guidance, FY2025 funding table, and a named RePORTER award record. The removed AIDS-only date row and old five-criterion review wording no longer describe the current parent route. PA-25-301's due-date table was checked again on October 6, 2026.
Data note: Grantsights data was checked on September 23, 2026 against NIH's R01 activity code page, PA-25-301, NIH standard due dates, NIH submission policies, NIH review guidance, NIH FY2025 extramural funding data, and the NIH RePORTER R01 award-history snapshot.
In this guide
- June 2026 Source Check: R01 Is A Route, Not One Competition
- Key Facts
- What NIH Doesn't Tell You
- R01 Fit Checklist
- 2026 Timing Matrix
- What FY2025 Success Rates Mean
- 4 R01 Readiness Signals Reviewers Notice
- 5 Conversations Before Submission
- Internal Planning Links
- 6 R01 Source Checks
- 5 Applicant Patterns That Should Pause Before R01
- 4 Signals To Confirm Before Specific Aims
- 3 Route Examples
- NIH Program Records to Compare Next
- FAQ
- Sources
June 2026 Source Check: R01 Is A Route, Not One Competition
As of June 2, 2026, NIH's R01 activity-code page still describes R01 as NIH's most common independent research project grant, while PA-25-301 remains the parent R01 route for applications that do not propose clinical trials. NIH standard due dates still put many new R01 applications on February 5, June 5, and October 5, with renewal, resubmission, and revision dates commonly one month later. NIH also notes that specific opportunities control final timing.
| Source checked June 2, 2026 | What it should change in the draft |
|---|---|
| NIH R01 activity code page (opens in a new tab) | Treat R01 as the project mechanism, then verify the specific notice and institute |
| PA-25-301 Parent R01 Clinical Trial Not Allowed (opens in a new tab) | Use only if the project does not propose clinical trials and fits a participating IC |
| NIH standard due dates (opens in a new tab) | Build the calendar after the institute, notice, and review-home questions are answered |
| NIH simplified review framework (opens in a new tab) | Recheck the draft against importance, rigor and feasibility, plus expertise and resources |
| NIH applicant guidance for simplified review (opens in a new tab) | Verify the activity code and NOFO instructions before moving a prior draft forward |
The snippet answer should stay narrow: NIH R01 grant searchers need due dates, parent notice fit, trial-status fit, success-rate pressure, and the reason "R01 eligible" is not the same as "R01 ready."
The R01 supports discrete, specified research projects. Applicants often search for "the R01 grant" as if it were one open program. The official source says otherwise. R01 applications move through parent notices, institute notices, clinical-trial allowed or not-allowed notices, special opportunities, and institute-specific practices.
Where official sources stop: NIH activity-code pages, parent notices, standard due dates, and RePORT success-rate tables explain the R01 system, but they do not tell a PI whether this project is R01-ready for a specific institute and study section. Our R01 screen starts with 6 gates: hypothesis, preliminary data, institute fit, study-section fit, clinical-trial status, and budget route. For example, one strong clinical idea with unclear trial status should pause before PA-25-301 and confirm the correct trial-allowed path.
Get research funding calls by email
About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.
No spam. Unsubscribe anytime.
Key Facts
6 facts shape the R01 decision in 2026. According to NIH, the R01 is used to support a discrete, specified research project.
| Item | 2026 read | Why it matters |
|---|---|---|
| Activity code | R01 | Main NIH research project grant mechanism |
| Parent notice example | PA-25-301 | Parent R01 clinical trial not allowed |
| Standard new due dates | February 5, June 5, October 5 | Most new R01s use these cycles |
| Renewal or resubmission dates | March 5, July 5, November 5 | A1 timing changes the calendar |
| FY2025 R01-equivalent success rate | 13.0% | NIH reported a large drop from FY2024 |
| Bad fit | Wrong institute, wrong clinical-trial status, weak aims | Do not submit before fit is solved |
What NIH Doesn't Tell You
3 hidden decisions matter before writing. NIH pages tell you what an R01 is and when standard receipt dates fall. They do not tell you whether your application belongs in a parent R01, a special notice, or a different activity code.
Grantsights analysis adds 3 decision layers:
- Institute fit: A good R01 topic can still fail if it is aimed at the wrong institute.
- Review fit: The study section must understand the science and the methods.
- Mechanism fit: Some ideas are better as R21, R03, R34, U01, K, or foundation funding before an R01.
The practical gap is that "R01 eligible" is a low bar. "R01 ready" means the project has a testable central hypothesis, enough preliminary data, an investigator team reviewers trust, and a review home that makes sense.
If the institution's main job is to train a cohort of researchers, an R01 is the wrong mechanism even when the science is strong. Compare the PA-25-168 Parent T32 institutional training route, including mentor capacity, trainee appointments, training outcomes, and the participating NIH Institute or Center, before turning a training plan into an R01 research proposal.
A common mistake in R01 planning is polishing text before solving fit. The hard truth: a well-written R01 can still score poorly if it lands with reviewers who see the project as too early, too descriptive, or outside their frame.
R01 Fit Checklist
6 checks should be finished before the application calendar controls the project.
| Fit question | Strong signal | Bad-fit signal |
|---|---|---|
| Hypothesis | Clear, testable, and tied to 2 to 4 aims | Descriptive project with no testable claim |
| Preliminary data | Shows feasibility and risk control | Pilot data missing for key method |
| Institute match | Program officer can name the likely institute fit | Topic sits between institutes with no owner |
| Study section | You can name likely panels and reviewer expertise | Review home is unclear |
| Budget | Costs match scope and NIH norms | Budget drives the project instead of science |
| Clinical trial status | Notice matches trial allowed, required, or not allowed | Trial status discovered late |
If you fail the study-section or institute test, do not submit yet. Fix that before polishing text.
2026 Timing Matrix
3 standard cycles matter for most R01 applicants. According to NIH standard due dates, new R01 applications commonly use February 5, June 5, and October 5.
| Application type | Standard cycle I | Standard cycle II | Standard cycle III |
|---|---|---|---|
| New R01 | February 5 | June 5 | October 5 |
| Renewal, resubmission, revision | March 5 | July 5 | November 5 |
| AIDS-related R01 when standard dates apply | Same new or renewal/resubmission/revision dates above | NIH removed dedicated AIDS dates from this parent notice in 2026 |
NIH's current standard-date policy (opens in a new tab) no longer has dedicated AIDS application dates. PA-25-301 marks the AIDS-specific dates as not applicable beginning with its June 2026 cycle. Applicants should always check the exact opportunity because not every program uses standard dates.
What FY2025 Success Rates Mean
3 numbers should change applicant behavior. According to NIH FY2025 extramural funding data, NIH reported 42,022 R01-equivalent applications in FY2025, 5,471 competing awards, and a 13.0% success rate. That is down from 18.7% in FY2024 and 21.6% in FY2023.
This does not mean every institute had the same rate. It means the margin for bad fit got smaller. A generic Specific Aims page, a weak study-section choice, or a missing preliminary data link can cost a cycle.
For a deeper data pass, use the NIH R01 success rate guide and then compare R01 with R21, R03, and K awards.
4 R01 Readiness Signals Reviewers Notice
4 signals often decide whether the application reads like an R01 or an early-stage concept.
| Signal | Strong R01 version | Weak R01 version |
|---|---|---|
| Central hypothesis | One testable claim that all aims support | A broad theme with loose aims |
| Preliminary data | Directly de-risks the main method or model | General lab capability only |
| Team fit | Each key person has a reason to be there | Names added for status |
| Review home | Study section expertise matches methods and field | Reviewers must guess the fit |
For example, one PI with a strong disease idea may still be better served by R21 if the model is new and feasibility data are thin. One university team with strong preliminary data and a clear study-section home may be ready for R01 even if the topic is high risk. The difference is not ambition. Under NIH's current simplified framework for most R01s, reviewers consider the importance of the research, rigor and feasibility, and the expertise and resources needed for this project. Confirm Section V of the exact notice before planning to that framework.
Based on our analysis of the complete FY2024 and FY2025 NIH RePORTER R01 project-year snapshot, a named Vanderbilt University Medical Center R01 award (opens in a new tab) received $5,665,215 in FY2024 for a multicenter Long COVID clinical trial. Its project number begins 1R01, marking a new application in the NIH record. This is a real-world example of why the activity code alone cannot select a notice: a clinical-trial project does not fit PA-25-301, which explicitly disallows proposed clinical trials. The award amount is for this named record, not a typical R01 budget or a success-rate denominator.
5 Conversations Before Submission
5 conversations can save an 8-month cycle.
- Ask the program officer whether the institute is the right home.
- Ask whether the notice allows the clinical-trial status you need.
- Ask a funded colleague which study sections would understand the methods.
- Ask a statistician or methods reviewer to attack the most fragile aim.
- Ask sponsored research whether budget, subawards, and human subjects documents will clear in time.
Grantsights' recommendation is to do these before the final aims draft. The #1 mistake is treating program officer contact as a formality after the science is already locked.
Internal Planning Links
- NIH grants complete guide
- How to write NIH Specific Aims
- NIH study sections explained
- NIH modular budget guide
- How to resubmit an NIH grant
- NIH grant scoring explained
- NIH Just-in-Time guide
- Grantsights grant search
If you are comparing mechanisms, start with NIH R01 vs R21 vs R03. If the weakness is the one-page thesis, use how to write NIH Specific Aims. If the problem is budget fit, use the NIH modular budget guide before the full budget is built.
6 R01 Source Checks
6 checks separate the official NIH answer from the applicant decision. NIH tells you what an R01 is, which parent notice is active, and when standard due dates fall. Grantsights adds the decision layer that decides whether the PI should use R01 at all.
| Source question | Official answer | Grantsights decision read |
|---|---|---|
| Activity code | NIH says R01 supports a discrete research project | The activity code is not enough. The project still needs institute, study section, and trial-status fit |
| Parent notice | PA-25-301 covers parent R01 clinical trial not allowed | If the project has any human-subjects intervention question, verify trial status before drafting |
| Due dates | New R01s commonly use February 5, June 5, and October 5 | The date is the last step. The first step is whether the aims can survive the target study section |
| Success rate | NIH reported 13.0% R01-equivalent success in FY2025 | A weak-fit R01 is now more expensive because the broad funding margin is smaller |
| Review model | NIH's 2025 review framework uses scored and sufficiency factors | Factor 3 can still block a good science idea if team, environment, or resources are not credible |
| Budget route | Modular budgets cover many applications up to $250,000 in direct costs per year | Budget route should follow science scope, not the applicant's fear of asking for what the work costs |
An R01 plan can meet the official eligibility test and still have the wrong review home. Our analysis found that R01 pages need a warning that official pages cannot easily give: "R01 eligible" is not the same as "R01 ready." That matters because a PI can meet the parent notice requirements and still lose the cycle through poor review fit.
If you're still guessing on institute, notice, or study section, don't treat the next due date as the plan. It isn't a writing problem yet, and you'll get a cleaner decision by solving route fit first.
The hard truth is that a polished R01 with the wrong review home can still lose the cycle, even in a strong lab.
5 Applicant Patterns That Should Pause Before R01
5 applicant patterns should slow down before using the next standard R01 date.
| Applicant pattern | Why it is risky | Better next action |
|---|---|---|
| New model, thin preliminary data | Reviewers may call the work too early for R01 | Test R21, R03, foundation, or pilot funding first |
| Multi-institute topic with no owner | Assignment can land away from the best reviewers | Ask program officers at 2 likely institutes before final aims |
| Human-subjects work with unclear trial status | Wrong notice choice can block review or award | Confirm clinical-trial status against the exact notice |
| Budget over $250,000 direct costs with no cost defense | Reviewers may see scope as inflated | Build a line-item reason for every major cost |
| Strong science with weak environment proof | Factor 3 can hurt the score even if aims are strong | Document core access, collaborators, data access, and institutional support |
For example, one PI with a new digital health intervention may think the R01 is the right route because the public-health question is large. If the trial status is not settled, the study section is unclear, and the team has not run the intervention at pilot scale, the better path may be R34, R21, or a foundation pilot before R01. A different PI with strong preliminary data, a clear institute home, and a study section that has reviewed similar methods may be ready for R01 even with a difficult topic.
This is the proprietary Grantsights finding for the page: the strongest R01 decision is not "submit by June 5." It is "prove the review home before the calendar controls the project." That changes the next action from drafting to routing.
4 Signals To Confirm Before Specific Aims
4 signals should be visible before the Specific Aims page becomes the center of the project.
- Institute signal: A program officer can explain why the project belongs in the institute and whether the notice is the right route.
- Study-section signal: The team can name likely review panels and explain why those reviewers will understand the methods.
- Mechanism signal: The team has compared R01 against R21, R03, R34, K, U01, SBIR/STTR, foundation, or pilot routes and can defend R01.
- Readiness signal: Preliminary data, team roles, budget, human-subjects status, and resource access are strong enough that reviewers do not need to guess.
If those 4 signals are weak, do not treat the next NIH deadline as the forcing function. A delayed R01 with a clearer review home is often better than an on-time R01 that reviewers see as early, misassigned, or over-scoped.
3 Route Examples
3 examples show how the same broad R01 idea can lead to different next steps.
| Project situation | R01 read | Better route if not ready |
|---|---|---|
| Established lab has preliminary data, clear hypothesis, and a known study section | Strong R01 candidate | Submit after program officer fit check |
| Early-stage lab has an interesting mechanism but only indirect feasibility data | Possible R01, but high risk | R21, R03, or foundation pilot |
| Clinical team wants to test an intervention but trial status and site capacity are unclear | Bad R01 timing | R34, pilot trial route, or trial-readiness work |
The bad-fit cases are not failures. They are route choices. The worst outcome is spending an R01 cycle to learn something that could have been found through a 30-minute program officer call and a study-section fit review.
NIH Program Records to Compare Next
Use these records when an R01 is only one possible NIH route:
- Complex brain disorders R21 program record
- Neurological biomarker clinical validation U01 record
- Dissemination and implementation research R01 record
- Substance use disorder intervention UG3/UH3 record
- Cryo-electron tomography R24 center record
- Kidney, urologic, and hematologic research training U2C record
- HIV and substance use research R01 record
- BRAIN recording and modulation technology record
- Tribal IRB enhancement R24 record
- NIGMS undergraduate research training T34 record
- Patient-oriented K23 career award record
- NICHD R03 clinical trial required record
- Audiologist K01 career award record
- Residential substance abuse treatment formula grant record
- NRSA individual fellowship program record
- Midcareer K24 patient-oriented research record
FAQ
Is the NIH R01 grant open in 2026?
Yes, but not as one single open competition. Applicants use parent notices, institute notices, and special notices with specific rules and dates.
What are the main new R01 due dates?
According to NIH standard due dates, many new R01 applications use February 5, June 5, and October 5. Always check the exact notice.
What was the FY2025 R01-equivalent success rate?
According to NIH, the FY2025 R01-equivalent success rate was 13.0%, with 42,022 applications and 5,471 competing awards.
When is R21 better than R01?
R21 is often better when the idea is high risk, early, and lacks enough preliminary data for reviewers to trust a full R01 scope.
What is the biggest R01 red flag?
The biggest red flag is unclear fit: wrong institute, wrong study section, wrong clinical-trial status, or aims that do not support one testable claim.
Sources
- NIH R01 activity code page (opens in a new tab)
- PA-25-301 Parent R01 Clinical Trial Not Allowed (opens in a new tab)
- NIH standard due dates (opens in a new tab)
- NIH submission policies (opens in a new tab)
- NIH simplified review framework (opens in a new tab)
- NIH applicant guidance for simplified review (opens in a new tab)
- NIH FY2025 extramural funding data (opens in a new tab)
- NIH RePORT success rates (opens in a new tab)
- NIH RePORTER named Vanderbilt R01 award (opens in a new tab)
Award data for this program
- NIH R01 winners: new FY2025 awardsNIH RePORTER, every FY2025 and FY2024 R01 record
- NIH R01 success rates and award dataAgency data and USAspending, FY2024-FY2025
- NIH paylines in FY2026Institute payline and funding policy pages
Next steps
Where to go next
These next pages help you move from research into a specific grant choice.
Open R01 index
Compare parent notices, trial lanes, and resubmission timing for R01 pages.
Check success rates
Use FY2025 R01-equivalent data before assuming a broad R01 cycle is realistic.
Fix Specific Aims
Use when the hypothesis, aims, and route memo are not ready for program officer review.
Find review home
Check whether reviewers will understand the methods, model, and field before submission.
Find grants that fit you
Free eligibility check: answer 9 questions and see ranked matches with deadlines and fit reasons.
Federal Program Records to Compare
Use these current program records to check eligibility, award history, deadlines, and past winners before your team commits writing time.
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)HHS · Open
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)HHS · Open
- Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)HHS · Open
- CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)HHS · Open
- In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)HHS · Closed
- Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)HHS · Open
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)HHS · Open
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)HHS · Open
Show 7 more program recordsShow fewer program records
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)HHS · Open
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)HHS · Open
- Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)HHS · Closed
- Strategies to Improve Health Outcomes and Reduce Health Disparities in Rural Populations (R01 Clinical Trial Optional)HHS · Closed
- Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials RequiredHHS · Upcoming
- Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)HHS · Closed
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)HHS · Closed
Frequently Asked Questions
What are the standard R01 due dates?
Most new R01 applications use February 5, June 5, and October 5. Renewal, resubmission, and revision applications commonly use March 5, July 5, and November 5.
Is an R01 one single competition?
No. R01 is an activity code. Applicants still need the right notice, institute, study section, budget path, and clinical-trial status.
When should an applicant not submit an R01?
Do not submit if institute fit, study-section fit, preliminary data, or clinical-trial status is unresolved.
What should happen before finalizing the Specific Aims page?
Send the aims to a program officer, test institute fit, and compare likely study sections before locking the application.
Last updated October 6, 2026. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
Complete Guide
NIH Grants 2026: R01, K Awards, R21, R35, SBIR
Compare NIH R01, K awards, R21, R03, R35, SBIR/STTR, success rates, deadlines, and program pages before choosing a route.
NIH BRG R01 Guide 2026: Eligibility
NIH BRG R01 guide for 2026: eligibility, $500K direct-cost cap, clinical-trial status, team fit, R01 route checks, and fit.
How to Read an NIH Summary Statement: Scores and Critiques
Your NIH summary statement has 3 reviewers' critiques and, if discussed, a 10-90 impact score. Decode the wording and decide: resubmit, revise or switch.
NIH Resubmission (A1): 1 Try, 37 Months, 1-Page Intro
NIH allows one A1 resubmission within 37 months of the A0, with a one-page Introduction. When to resubmit, when to go new, and how to answer reviewers.
NIH Specific Aims Page: 1-Page Structure and 2-3 Aims
Write the 1-page NIH Specific Aims: what is known, the gap, your objective and hypothesis, then 2-3 independent aims with expected outcomes and impact.
NIH Biosketch 2026: Format, Sections & Reviewer Tips
NIH biosketch 2026: the SciENcv Common Form and NIH Supplement, the 3,500-character personal statement, 5 contributions, and what reviewers read first.